Healthcare providers should direct questions about the revocation of Emergency Use Authorization (EUA) 90, bamlanivimab alone, to Eli Lilly and Company at 1-855-LillyC19 (1-855-545-5921).
Healthcare providers should direct questions about the revocation of Emergency Use Authorization (EUA) 90, bamlanivimab alone, to Eli Lilly and Company at 1-855-LillyC19 (1-855-545-5921).